Facioscapulohumeral muscular dystrophy is an inherited condition causing progressive weakness that classically affects the face, shoulder blade (scapular), and upper arm (humeral) muscles.

It commonly causes weakness around the shoulder blade and upper arm, which can significantly affect the ability to raise the arms and perform overhead tasks.

Yes, it's an inherited condition, most commonly caused by a specific genetic change on chromosome 4, typically passed in an autosomal dominant pattern.

Diagnosis typically involves a clinical exam noting the characteristic pattern of weakness, along with genetic testing to confirm the diagnosis.

There's currently no cure, though treatment can help manage symptoms, and research into targeted therapies continues.

Treatment often includes physical and occupational therapy, and in some cases, surgical stabilization of the shoulder blade to improve arm function.

Yes, progressive wasting of the shoulder blade and upper arm muscles is a characteristic feature of this condition.

Yes, therapy plays an important role in maintaining strength, flexibility, and function for as long as possible.

While it primarily affects the shoulder and upper arm, some hand and grip involvement can occur as the condition progresses in certain individuals.

Yes, occupational therapy can help with adapting daily tasks, particularly those requiring overhead arm use, and maximizing independence.

Yes, characteristic facial muscle weakness, sometimes affecting expression, is a classic feature alongside the shoulder and arm involvement.

Yes, genetic testing is commonly used to confirm the diagnosis by identifying the characteristic genetic change associated with this condition.

Yes, weakness affecting the shoulder blade's stability commonly and often significantly limits the ability to raise the arms above shoulder level.

Yes, it's generally a slowly progressive condition, though the rate and pattern of progression can vary among individuals.

Yes, asymmetric involvement, with one side more affected than the other, particularly early on, is a recognized pattern in this condition.

Yes, in some cases, it can be associated with hearing changes or retinal blood vessel abnormalities, which may be monitored as part of comprehensive care.

In some cases, screening for associated hearing or retinal changes may be recommended as part of comprehensive evaluation.

In some individuals, particularly with more extensive disease, lower limb involvement can also occur, though shoulder and arm symptoms are often more classically prominent.

Yes, given its inherited, typically dominant pattern, genetic counseling is often recommended for affected families.

Depending on severity and job demands, particularly those requiring overhead arm use or significant shoulder strength, this condition can significantly affect work capacity.

Yes, there's active ongoing research, including into therapies specifically targeting the underlying genetic mechanism of this condition.

Yes, various assistive devices, particularly for overhead tasks, can become increasingly helpful as the condition progresses.

Yes, in some cases, a surgical procedure to fix the shoulder blade in a more stable position can help improve arm function for select patients.

This is understandable, and your neurologist can help provide realistic expectations based on your specific presentation and the generally variable course of this condition.

Yes, care often involves a multidisciplinary team, including neurologists, physical and occupational therapists, and sometimes orthopedic surgeons.

Yes, given its progressive nature, though often slower than some other muscular dystrophies, this condition can lead to increasing need for support over time.

Yes, treatment and support plans are typically adjusted over time to address changing symptoms and needs.

Yes, given the progressive nature of this condition, proactive planning for future care needs, with support from your care team, is often recommended.

Appropriate, carefully guided exercise can be beneficial for many people with this condition, tailored to avoid overexertion and guided by your care team.

Yes, given active research into this condition, clinical trials investigating new treatments may be available, and your neurologist can discuss potential options.

Yes, living with a chronic, progressive condition, particularly one affecting visible facial and shoulder muscles, can significantly affect emotional well-being.

Yes, connecting with others facing this specific condition can provide valuable emotional support and practical advice.

Yes, this condition is often diagnosed in adolescence or adulthood, though age of onset and severity can vary considerably.

Depending on symptom severity, some accommodations for physically demanding school activities, particularly those requiring overhead arm use, may be helpful.

Yes, regular follow-up is important to monitor disease progression, adjust treatment, and address any new or changing symptoms.

Yes, fatigue is a commonly reported symptom alongside specific muscle weakness in this condition.

Yes, therapy and assistive strategies often focus on maximizing independence and quality of life for as long as possible.

Yes, depending on severity and the specific pattern of muscle involvement, this condition can significantly affect daily function and quality of life.

Yes, genetic testing for the characteristic genetic change is considered the definitive way to confirm this diagnosis.

Yes, caregiver support is a valuable aspect of comprehensive care for families affected by this condition.

Yes, earlier diagnosis allows for more timely initiation of supportive treatments, monitoring for associated features, and access to appropriate resources.

Yes, even for this progressive condition, therapy can help maintain arm and shoulder function for as long as possible.

As the condition progresses and potentially affects broader arm strength, endurance during repetitive tasks can become affected.

This is understandable, and addressing both the functional and emotional aspects of visible changes is an important part of comprehensive care.

Yes, depending on disease progression, particularly overhead tasks like hair care, self-care activities can become increasingly affected.

Yes, your care team should provide clear information about the typically variable, often slowly progressive course of this specific condition.

Yes, once the specific genetic change is identified, testing for family members can be discussed as part of genetic counseling.

Yes, scapular winging, where the shoulder blade protrudes abnormally due to muscle weakness, is a classic finding in facioscapulohumeral muscular dystrophy.

Yes, facial muscle weakness can affect the ability to fully smile or make certain facial expressions, which is a characteristic feature of this condition.

See a doctor for unexplained, progressive weakness affecting the face, shoulder blades, or upper arms, particularly with any family history of muscular dystrophy.